Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Dexamethasone and Betamethasone in Healthy Females
NCT03668860Phase 1Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Sep 2018
- Primary completion
- Feb 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dexamethasone and betamethasone in preterm birth (8 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoints: Pharmacokinetic parameters at 23 days and Pharmacodynamic parameters at 23 days. Started Sep 2018; status: completed.
02
Drugs
dexamethasonebetamethasone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT03668860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03668860.